Mount Sinai Doctors
Accepting New Patients
Tara Balija, MD
Surgery, Breast Cancer - Surgery
About Me
Tara Balija, MD, FACS, is a board-certified fellowship-trained breast surgical oncologist. She is a strong proponent of compassionate and equitable healthcare and believes in the importance of partnering with her patients to optimize their outcomes. While she is a breast conserving surgery advocate who performs oncoplastic techniques to minimize scarring for lumpectomies, she is also well versed in nipple-sparing mastectomies and skin sparing mastectomies in eligible patients. With over 10 years of experience, Dr. Balija sees patients with a wide breadth of breast disease, including patients who need high risk breast cancer screening due to a family history of breast cancer or atypia, abnormal breast imaging and exams, and breast cancer.
Dr. Balija graduated from Columbia University with a Bachelor of Arts in Biology. She received her MD with a Distinction in Research from the Mount Sinai School of Medicine (now the Icahn School of Medicine at Mount Sinai). She completed General Surgery residency at Rutgers-Robert Wood Johnson Medical School and fellowship training in Breast Surgical Oncology at the Rutgers-Cancer Institute of New Jersey.
As Assistant Professor of Surgery, she has been involved with educating the next generation of medical students and residents at medical schools in New York and New Jersey. Throughout her career, Dr. Balija has continued to contribute to the body of knowledge in breast surgery through various research studies and has served as a site principal investigator for multi-institutional clinical trials including:
- COMET Trial: Comparing an Operation to Monitoring, with or without Endocrine Therapy for low-risk DCIS
- A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Receiving Neoadjuvant Chemotherapy
- DCIS: RECAST Trial: Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Dr. Balija sees patients at Mount Sinai West.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Tara Balija, MD, FACS, is a board-certified fellowship-trained breast surgical oncologist. She is a strong proponent of compassionate and equitable healthcare and believes in the importance of partnering with her patients to optimize their outcomes. While she is a breast conserving surgery advocate who performs oncoplastic techniques to minimize scarring for lumpectomies, she is also well versed in nipple-sparing mastectomies and skin sparing mastectomies in eligible patients. With over 10 years of experience, Dr. Balija sees patients with a wide breadth of breast disease, including patients who need high risk breast cancer screening due to a family history of breast cancer or atypia, abnormal breast imaging and exams, and breast cancer.
Dr. Balija graduated from Columbia University with a Bachelor of Arts in Biology. She received her MD with a Distinction in Research from the Mount Sinai School of Medicine (now the Icahn School of Medicine at Mount Sinai). She completed General Surgery residency at Rutgers-Robert Wood Johnson Medical School and fellowship training in Breast Surgical Oncology at the Rutgers-Cancer Institute of New Jersey.
As Assistant Professor of Surgery, she has been involved with educating the next generation of medical students and residents at medical schools in New York and New Jersey. Throughout her career, Dr. Balija has continued to contribute to the body of knowledge in breast surgery through various research studies and has served as a site principal investigator for multi-institutional clinical trials including:
- COMET Trial: Comparing an Operation to Monitoring, with or without Endocrine Therapy for low-risk DCIS
- A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Receiving Neoadjuvant Chemotherapy
- DCIS: RECAST Trial: Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Dr. Balija sees patients at Mount Sinai West.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
